Purchases and Sales Made in Q3 2024 in Spero Therapeutics, Inc. (SPRO)
This table provides information about the institutional ownership of Spero Therapeutics, Inc. (SPRO) during Q3 2024. The information is specifically focused on institutions that hold shares of Spero Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
21.1K+ 91.65% |
$25.2K - $31.7K
|
44.2K
$42K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
- |
17.2K+ 5195.77% |
$20.5K - $25.8K
|
17.5K
$16.7K
|
|
|
Oct 23, 2024
Q3 2024
|
Pfg Investments, LLC
Woodbury, NY |
BUY
|
- |
14KNew |
$16.6K - $21K
|
14K
$13.3K
|
|
|
Nov 12, 2024
Q3 2024
|
National Bank Of Canada
|
BUY
|
- |
10KNew |
$11.9K - $15K
|
10K
$9.5K
|
|
|
Nov 13, 2024
Q3 2024
|
Cibc Private Wealth Group, LLC
|
BUY
|
- |
2.88KNew |
$3.43K - $4.32K
|
2.88K
$2.74K
|
|
|
Nov 08, 2024
Q3 2024
|
Simplex Trading, LLC
|
BUY
|
- |
921New |
$1.1K - $1.38K
|
921
$875
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
96+ 1.73% |
$114 - $144
|
5.65K
$5.37K
|
|
|
Nov 12, 2024
Q3 2024
|
Northwestern Mutual Wealth Management CO
|
BUY
|
- |
50New |
$59.5 - $75
|
50
$47.5
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-7- 2.54% |
$8.33 - $10.5
|
269
$256
|
|
|
Nov 13, 2024
Q3 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-800- 80.0% |
$952 - $1.2K
|
200
$190
|
|
|
Nov 13, 2024
Q3 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-806- 0.72% |
$959 - $1.21K
|
111K
$106K
|
|
|
Nov 13, 2024
Q3 2024
|
Mackenzie Financial Corp
Toronto Ontario, A6 |
SELL
|
- |
-826- 2.52% |
$983 - $1.24K
|
31.9K
$30.3K
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-1.3K- 0.13% |
$1.55K - $1.95K
|
975K
$926K
|
|
|
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-6.91K- 0.39% |
$8.22K - $10.4K
|
1.76M
$1.68M
|
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-11K- 2.23% |
$13.1K - $16.5K
|
481K
$457K
|
|
|
Nov 14, 2024
Q3 2024
|
Man Group PLC
London, X0 |
SELL
|
- |
-35K- 47.62% |
$41.6K - $52.5K
|
38.5K
$36.6K
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-66.3K- 67.34% |
$79K - $99.5K
|
32.2K
$30.6K
|
|
|
Nov 12, 2024
Q3 2024
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-132K- 24.74% |
$158K - $199K
|
403K
$383K
|
|
|
Nov 14, 2024
Q3 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-175K- 19.1% |
$209K - $263K
|
743K
$706K
|
|
|
Nov 14, 2024
Q3 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-231K- 73.91% |
$274K - $346K
|
81.4K
$77.4K
|